University Policy Updates

Temple has developed new and revised policies for staff in response to the COVID-19 pandemic. Staff who plan to return to campus should be informed of new policies and certain policy modifications.

Sick Time Policy Modification

One of the most important steps to keeping yourself and others safe is to monitor your own health and, if you are sick and/or exposed to COVID-19, stay home.

Temple will temporarily modify its sick leave policy beginning July 1, 2020, and ending Dec. 31, 2020. During this time period, bargaining and non-bargaining unit employees may not only request sick leave for their own illness, but they may also request sick leave from their current and banked time so they may

  • isolate due to acquiring COVID-19 and/or quarantine due to being identified as a “close contact” of someone diagnosed with COVID-19, and/or
  • care for family members who are sick due to COVID-19.

​As with all absences, Temple may require documentation. The university will also continue to follow all relevant rules regarding attendance as well as Family Medical Leave Act (FMLA) requirements. If you need additional information regarding FMLA leave, contact Absence Management at 215-926-2282 or email

The university will continue to monitor the effectiveness and challenges associated with this modification. This flexibility modification may cease prior to Dec. 31, 2020, in any department in which excessive use of sick time may occur.

Travel Restrictions

The Philadelphia Department of Public Health (PDPH) recently issued advice for individuals returning to Pennsylvania following travel to numerous states in the country because of recent increases in COVID-19 cases. Learn more about the PDPH’s travel recommendations.  

To keep our campus community as safe as possible, the university is following this recommendation by prohibiting university-supported travel to these states and requiring students and staff to remain off campus for a 14-day period following return from any of the states indicated in the Philadelphia recommendation.